Previous 10 | Next 10 |
WIXOM, Mich., June 10, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announ...
Rockwell Medical (NASDAQ: RMTI ) has filed a New Drug Submission (“NDS”) with Health Canada for Triferic AVNU (ferric pyrophosphate citrate). More news on: Rockwell Medical, Inc., Healthcare stocks news, Stocks on the move, Read more ...
WIXOM, Mich., May 26, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announc...
Rockwell Medical, Inc. (RMTI) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Claudia Styslinger - Assistant Vice President at Argot Partners, LLC Russell Ellison - President and Chief Executive Officer Marc Hoffman - Chief Medical Officer Tim Chol...
Rockwell Medical (NASDAQ: RMTI ): Q1 GAAP EPS of -$0.12 beats by $0.01 . More news on: Rockwell Medical, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
-Q1 2020 revenue of $15.9 million- -Received FDA Approval of Triferic® AVNU TM - -Significant expansion of Triferic (ferric pyrophosphate citrate) Dialysate Evaluation Programs during Q1 2020- -Retrospective real-world analysis over 18 months shows reduction in ESA and tr...
Rockwell Medical (NASDAQ: RMTI), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that its Board of Directors has appointed Russell H. Ellison, M.D., M.Sc. as president and chief executive officer, eff...
WIXOM, Mich., April 20, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today annou...
WIXOM, Mich., March 31, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, announced today the appoin...
Bristol-Myers Receives FDA Approval for Celgene’s Ozanimod Bristol-Myers Squibb ( BMY ) (BMYMP) announced that it has received the FDA approval for Ozanimod, an MS drug it acquired through its purchase of Celgene business. The approval comes after quite a few roadblocks including ...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...